LianBio President and Chief Strategy Officer Debra Yu resigns effective Jan 1, 2023

LianBio

Debra Yu, President and CSO, resigns effective Jan 1, 2023 to pursue other business opportunities.
Yu entered a consulting agreement with LianBio from Jan 1 to June 30, 2023 to facilitate transition.
Separation agreement includes 12 months base salary, 14-month lump sum, and extended option exercisability.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Debra Yu

President and Chief Strategy Officer

LIANY · LianBio

Effective: 2023-01-01
Filed: December 13, 2022, 6:59 PM ET

Debra Yu, the Company’s President and Chief Strategy Officer, has decided to resign from the Company, effective January 1, 2023

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Debra Yu resigned as President and Chief Strategy Officer at LianBio.

Action: resigned
Role: President and Chief Strategy Officer

Exact text from the filing

Debra Yu, the Company’s President and Chief Strategy Officer, has decided to resign from the Company, effective January 1, 2023

View on SEC.gov

LianBio filing history →

Source: SEC EDGAR

accession 0001831283-22-000079

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.